5th TCR-based Therapies for Solid Tumors Summit 2024
Evvnt Promotion / evvnt
Archiv
23.04.2024 - 25.04.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 AM - 5:30 PM
Kongressthemen
Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential in targeting solid tumors. These therapies offer promising avenues for enhancing treatment methodologies, thereby fostering optimism for improved outcomes among patients grappling with these challenging conditions.
Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential in targeting solid tumors. These therapies offer promising avenues for enhancing treatment methodologies, thereby fostering optimism for improved outcomes among patients grappling with these challenging conditions.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2147535-3?pid=4832
Speakers: Alfred Lim, Head of Pipeline Research, Etcembly, Andrew Bayliffe, Chief Scientific Officer, Marengo Therapeutics, Cagan Gurer, Vice President Disovery, TScan Therapeutics, and more
Brochure: https://go.evvnt.com/2147535-3?pid=4832
Speakers: Alfred Lim, Head of Pipeline Research, Etcembly, Andrew Bayliffe, Chief Scientific Officer, Marengo Therapeutics, Cagan Gurer, Vice President Disovery, TScan Therapeutics, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2147535-2?pid=4832
Frau Kate Woodford
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
